Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed the stock exchanges that its Board of Directors will meet on Thursday, August 14, 2025, at 4:00 PM. The main agenda is to consider and adopt the unaudited standalone and consolidated financial statements for the quarter ended June 30, 2025 (Q1 FY26). The Board will also review the Limited Review Reports from the Statutory Auditor on these results. The trading window for designated persons and connected parties remains closed until 48 hours after the results are declared.
This is a routine procedural filing ahead of the Q1 FY26 earnings announcement. Investors should wait for the actual results on/after August 14 to assess the company's financial performance. No material business decision is implied by this notice.